BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19287456)

  • 1. Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome.
    Millar EK; Dean JL; McNeil CM; O'Toole SA; Henshall SM; Tran T; Lin J; Quong A; Comstock CE; Witkiewicz A; Musgrove EA; Rui H; Lemarchand L; Setiawan VW; Haiman CA; Knudsen KE; Sutherland RL; Knudsen ES
    Oncogene; 2009 Apr; 28(15):1812-20. PubMed ID: 19287456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome.
    Abramson VG; Troxel AB; Feldman M; Mies C; Wang Y; Sherman L; McNally S; Diehl A; Demichele A
    Anticancer Res; 2010 Apr; 30(4):1279-85. PubMed ID: 20530440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.
    Comstock CE; Augello MA; Benito RP; Karch J; Tran TH; Utama FE; Tindall EA; Wang Y; Burd CJ; Groh EM; Hoang HN; Giles GG; Severi G; Hayes VM; Henderson BE; Le Marchand L; Kolonel LN; Haiman CA; Baffa R; Gomella LG; Knudsen ES; Rui H; Henshall SM; Sutherland RL; Knudsen KE
    Clin Cancer Res; 2009 Sep; 15(17):5338-49. PubMed ID: 19706803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.
    Gupta VK; Feber A; Xi L; Pennathur A; Wu M; Luketich JD; Godfrey TE
    Clin Cancer Res; 2008 Dec; 14(23):7804-12. PubMed ID: 19047108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.
    Burd CJ; Petre CE; Morey LM; Wang Y; Revelo MP; Haiman CA; Lu S; Fenoglio-Preiser CM; Li J; Knudsen ES; Wong J; Knudsen KE
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2190-5. PubMed ID: 16461912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
    Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
    Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
    Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
    Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.
    Paronetto MP; Cappellari M; Busà R; Pedrotti S; Vitali R; Comstock C; Hyslop T; Knudsen KE; Sette C
    Cancer Res; 2010 Jan; 70(1):229-39. PubMed ID: 20028857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1b represses breast cancer cell growth by antagonizing the action of cyclin D1a on estrogen receptor alpha-mediated transcription.
    Zhu J; Sen S; Wei C; Frazier ML
    Int J Oncol; 2010 Jan; 36(1):39-48. PubMed ID: 19956831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer.
    Sanchez G; Bittencourt D; Laud K; Barbier J; Delattre O; Auboeuf D; Dutertre M
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6004-9. PubMed ID: 18413612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression Of Cyclin D1 Protein Isoforms And Its Prognostic Significance In Cervical Cancer.
    Gu J; Zhang X; Yang Z; Wang N
    Cancer Manag Res; 2019; 11():9073-9083. PubMed ID: 31695498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.
    Solomon DA; Wang Y; Fox SR; Lambeck TC; Giesting S; Lan Z; Senderowicz AM; Conti CJ; Knudsen ES
    J Biol Chem; 2003 Aug; 278(32):30339-47. PubMed ID: 12746453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1b splice variant promotes αvβ3-mediated adhesion and invasive migration of breast cancer cells.
    Wu FH; Luo LQ; Liu Y; Zhan QX; Luo C; Luo J; Zhang GM; Feng ZH
    Cancer Lett; 2014 Dec; 355(1):159-67. PubMed ID: 25193465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).
    Rojas P; Benavides F; Blando J; Perez C; Cardenas K; Richie E; Knudsen ES; Johnson DG; Senderowicz AM; Rodriguez-Puebla ML; Conti CJ
    Mol Carcinog; 2009 Jun; 48(6):508-16. PubMed ID: 18942117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer.
    Myklebust MP; Li Z; Tran TH; Rui H; Knudsen ES; Elsaleh H; Fluge Ø; Vonen B; Myrvold HE; Leh S; Tveit KM; Pestell RG; Dahl O
    Br J Cancer; 2012 Nov; 107(10):1684-91. PubMed ID: 23099809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
    Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
    Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma.
    Krieger S; Gauduchon J; Roussel M; Troussard X; Sola B
    BMC Cancer; 2006 Oct; 6():238. PubMed ID: 17022831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin K and cyclin D1b are oncogenic in myeloma cells.
    Marsaud V; Tchakarska G; Andrieux G; Liu JM; Dembele D; Jost B; Wdzieczak-Bakala J; Renoir JM; Sola B
    Mol Cancer; 2010 May; 9():103. PubMed ID: 20459741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists.
    Wang Y; Dean JL; Millar EK; Tran TH; McNeil CM; Burd CJ; Henshall SM; Utama FE; Witkiewicz A; Rui H; Sutherland RL; Knudsen KE; Knudsen ES
    Cancer Res; 2008 Jul; 68(14):5628-38. PubMed ID: 18632615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    Ortiz AB; Garcia D; Vicente Y; Palka M; Bellas C; Martin P
    PLoS One; 2017; 12(11):e0188068. PubMed ID: 29140993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.